Records containing: Overactive Bladder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-07-01Evaluation of Anticholinergic Treatment Response and Predictive Factors in Pediatric Overactive Bladder
-
CLINICAL_TRIALS study record update · 2025-06-05Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder
-
CLINICAL_TRIALS study record update · 2025-06-03Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children
-
CLINICAL_TRIALS study record update · 2025-05-22Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder: A Multicenter, Randomized, Controlled, Noninferiority Trial
-
CLINICAL_TRIALS study record update · 2025-05-09Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-06Transvaginal Electrical Stimulation for the Treatment of OAB-dry
-
CLINICAL_TRIALS study record update · 2025-05-04Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients
-
CLINICAL_TRIALS study record update · 2025-04-20Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women: A Randomized Double-Blind, Placebo-Controlled Study
-
CLINICAL_TRIALS study record update · 2025-04-20Investigation of Effects of External Electrical Stimulation in Women With Vaginal Laxity
-
CLINICAL_TRIALS study record update · 2025-04-13Procedural Discomfort Related to Number of Intradetrusor Injections of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Randomized Control Trial of an Alternate Reconstitution Volume and Injection Template Protocol
-
CLINICAL_TRIALS study record update · 2025-03-06Minimizing Pain During Office Intradetrussor Botox Injection: A Prospective Randomized Controlled Trial Comparing Two Protocols
-
CLINICAL_TRIALS study record update · 2025-02-26A Prospective Efficacy Study Comparing FREquency of Use and Efficacy of a Personalized Surgery-free Wearable and Personalized Bladder Modulation System With Objective Confirmation of Nerve Activation for Use in the Home by Subjects With OverActive Bladder Syndrome
-
CLINICAL_TRIALS study record update · 2025-02-26Evaluation of the Tensi+ Device for the Treatment of Overactive Bladder: Prospective Study
-
CLINICAL_TRIALS study record update · 2025-02-19Urinary Tract Infection Prophylaxis In Intradetrusor OnabotulinumtoxinA Procedures: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-02-14Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-02-03Lidocaine Patches Prior to Percutaneous Nerve Evaluation
-
CLINICAL_TRIALS study record update · 2025-01-20Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.
-
CLINICAL_TRIALS study record update · 2024-12-27Composur, a Patient-centric, Phase IV, Open-label, Prospective, Real World US Study to Evaluate Vibegron on Patient Treatment Satisfaction, Quality of Life, and Healthcare Resource Utilization in Overactive Bladder
-
CLINICAL_TRIALS study record update · 2024-11-19Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections: a Prospective Randomized Superiority Trial
-
CLINICAL_TRIALS study record update · 2024-11-07A Randomized, Double-blind, Placebo-controlled, Parallel-group, and Phase IV Study of Efficacy and Safety of Solifenacin Succinate in Patients With Overactive Bladder After TURP or PVP
-
CLINICAL_TRIALS study record update · 2024-10-31A Multicentre, Open-Label, Single Dose, Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)
-
CLINICAL_TRIALS study record update · 2024-10-31Non-Interventional Study Assessing Quality of Life, Treatment Satisfaction, Resource Utilisation, and Persistence With Treatment in Overactive Bladder (OAB) Patients Prescribed Betmiga® - A Multicenter Non-interventional Post Authorisation Study (PAS)
-
CLINICAL_TRIALS study record update · 2024-10-30The Preference of a Culturally and Linguistic Diverse (CALD) Population for Second Line OAB Therapy: a Discrete Choice Experiment
-
CLINICAL_TRIALS study record update · 2024-10-29Effect of Pelvic Floor Down-training on Women With Idiopathic Overactive Bladder
-
CLINICAL_TRIALS study record update · 2024-10-22A Multicentre, Open-label, Single Ascending Dose Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS Tablets in Pediatric Subjects From 5 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)